Sailax Pharma Consulting
Patient safety is at the heart of healthcare innovation, and effective pharmacovigilance is essential to maintaining trust and regulatory compliance. At Sailax Pharma Consulting, we deliver end-to-end pharmacovigilance and drug safety solutions that help organizations monitor, assess, and manage the safety of their products throughout the entire lifecycle. Our services ensure that safety data is collected, analyzed, and reported in compliance with global regulations, enabling organizations to protect patients, sustain regulatory approvals, and strengthen their market presence.

Patient safety is at the heart of healthcare innovation, and effective pharmacovigilance is essential to maintaining trust and regulatory compliance. At Sailax Pharma Consulting, we deliver end-to-end pharmacovigilance and drug safety solutions that help organizations monitor, assess, and manage the safety of their products throughout the entire lifecycle. Our services ensure that safety data is collected, analyzed, and reported in compliance with global regulations, enabling organizations to protect patients, sustain regulatory approvals, and strengthen their market presence.
Who we support
Our pharmacovigilance and drug safety services are designed for: Pharmaceutical companies requiring global safety surveillance systems. Biotech firms developing novel therapies with rigorous safety requirements. Medical device manufacturers needing compliance with post-market safety regulations. Nutraceutical and cosmetic companies entering regulated markets with safety oversight needs.
Explore the modules we tailor for your regulatory program.

Management of adverse event reports in compliance with global standards.

Clear value at every stage of partnership.
Ensure compliance with international safety standards and inspections.
Protect patients with robust surveillance and risk management.
Centralized systems and expert oversight streamline reporting.
Early detection and resolution of safety signals prevent major regulatory or market setbacks.
Ongoing compliance supports product longevity and global acceptance.
Our pharmacovigilance practices comply with: ICH E2E & E2F guidelines, FDA, EMA, MHRA, CDSCO, and Health Canada PV requirements, Good Pharmacovigilance Practice (GVP) modules, 21 CFR Part 11 (for electronic records & submissions), WHO drug safety monitoring standards.
Ensure patient safety while maintaining global compliance. Partner with Sailax Pharma Consulting to build a robust pharmacovigilance framework that safeguards your products and enhances market trust. 📩 Contact us today to discuss how our pharmacovigilance expertise can strengthen your safety and compliance systems.